{
    "ucits": false,
    "type": "ETC",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Derivatives, Synthetic replication, Inverse exposure, Commodity futures rolling costs",
    "classification": "complex",
    "supporting_data": "The product is WisdomTree Silver 3x Daily Short ETC, which provides leveraged short exposure (-3x daily) to the Solactive Silver Commodity Futures SL Index. It uses futures contracts on silver, with daily leverage reset and compounding effects, making the return path complex and volatile. The ETC is fully collateralised but involves derivative contracts (commodity futures), leverage (3x short), and inverse exposure. The product documentation explicitly states it is 'not simple and may be difficult to understand' and is classified as highest risk (7/7). The use of commodity futures with rolling (roll costs, contango/backwardation effects) and daily leverage reset introduces complexity beyond a standard UCITS ETF. The product is an ETC, not a UCITS ETF, and is governed as a collateralised debt security, not a UCITS fund. According to MiFID II rules and ESMA guidance, such leveraged, derivative-based, inverse ETCs are complex financial instruments requiring appropriateness assessment. The presence of leverage, derivatives integral to the strategy, synthetic replication (via futures), and inverse leveraged exposure all contribute to complexity. The product does not meet the criteria of Article 57 of the Commission Delegated Regulation for non-complex instruments, as it embeds derivatives, has leverage, and involves complex payoff structures. Therefore, it is classified as complex under MiFID II.",
    "explanation": "This ETC is not UCITS compliant and is structured as a collateralised debt security with leveraged inverse exposure to silver futures. It uses derivatives (commodity futures) as an inherent part of its investment objective, with 3x leverage and daily reset, which introduces significant complexity including counterparty and collateral risks, compounding effects, and roll costs. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features make the product complex. The product's own KID states it is 'not simple and may be difficult to understand' and has the highest risk rating. Hence, it is classified as complex."
}